Evidence map›Paper›PMID 37109701›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against

Fatemeh Nikoomanesh, Mahsa Falahatinejad, Lucia Černáková, André Luis Souza Dos Santos, Shahla Roudbar Mohammadi, Mitra Rafiee, Célia Fortuna Rodrigues, Maryam Roudbary

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Natural product based approaches to overcomeFrontiers in antibiotics · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Physiological adventures inMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  9. Article
  10. Antifungal susceptibility pattern ofFrontiers in cellular and infection microbiology · 2024
    Article
  11. Article
  12. Molecular association ofFrontiers in cellular and infection microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 4 countries.

Fatemeh NikoomaneshInfectious Disease Research Center, Birjand University of Medical Sciences, Birjand 9717853577, Iran.
Mahsa FalahatinejadDepartment of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115111, Iran.
Lucia ČernákováDepartment of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, 842 15 Bratislava, Slovakia.ORCID 0000-0001-5300-3254
André Luis Souza Dos SantosDepartment of General Microbiology, Microbiology Institute Paulo de Góes, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-901, RJ, Brazil.ORCID 0000-0003-0821-8592
Shahla Roudbar MohammadiDepartment of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115111, Iran.
Mitra RafieeDepartment of Immunology, School of Medicine, Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand 9717853577, Iran.
Célia Fortuna RodriguesLEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.ORCID 0000-0001-8633-2230
Maryam RoudbaryDepartment of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.
Birjand University of Medical Sciences · IRTarbiat Modares University · IRComenius University Bratislava · SKIran University of Medical Sciences · IRUniversidade do Porto · PTUniversidade Federal do Rio de Janeiro · BR

Funding

Iran 9929918907
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antifungal AgentsCandidiasis, VulvovaginalAzolesCandidaCandida albicansFarnesolFemaleFluconazoleHumansItraconazoleAntifungal AgentsAzolesFarnesolFluconazoleItraconazoleazolesfarnesolresistancevulvovaginal candidiasis

Identifiers

PMID37109701
PMCPMC10143126
OpenAlexW4364377644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.